Mirjam Renovanz Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

1/2020

Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mirjam Renovanz Research Topics

Disease

17	Neoplasms (Cancer) 06/2024 - 05/2014
10	Glioma (Gliomas) 05/2024 - 05/2014
6	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 08/2015
4	Meningioma (Meningiomas) 02/2022 - 12/2020
3	Fatigue 12/2021 - 11/2020
2	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2018
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2023
1	Polyneuropathies (Polyneuropathy) 05/2023
1	Nervous System Neoplasms (Neoplasms, Nervous System) 01/2023
1	Anxiety Disorders (Anxiety Disorder) 12/2022
1	Ependymoma 11/2022
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 02/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Chronic Disease (Chronic Diseases) 09/2021
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Residual Neoplasm 01/2021
1	Hydrocephalus (Hydrocephaly) 03/2020
1	Cysts 03/2020
1	Cough 03/2020
1	Pain (Aches) 03/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2017
1	Ischemic Stroke 07/2017
1	Neurologic Manifestations (Neurological Manifestations) 06/2017
1	Discitis 03/2017
1	Astrocytoma (Pilocytic Astrocytoma) 08/2015

Drug/Important Bio-Agent (IBA)

4	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 08/2015
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 06/2024 - 01/2023
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2021 - 11/2020
2	Bevacizumab (Avastin)FDA Link 02/2019 - 07/2017
2	Indicators and Reagents (Reagents)IBA 02/2017 - 01/2016
1	Immune Checkpoint InhibitorsIBA 05/2023
1	TabletsIBA 12/2022
1	PAX6 Transcription FactorIBA 11/2022
1	Radioisotopes (Radionuclides)IBA 02/2022
1	somatostatin receptor type 1IBA 02/2022
1	somatostatin receptor 2IBA 02/2022
1	Amino Acids FDA Link 01/2022
1	CytokinesIBA 10/2021
1	Histones (Histone)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020
1	depatuxizumab mafodotinIBA 01/2020
1	Monoclonal AntibodiesIBA 07/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017
1	Formaldehyde (Formol)FDA Link 01/2016
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2016
1	Alkylating AgentsIBA 01/2016
1	EpitopesIBA 01/2015

Therapy/Procedure

13	Therapeutics 06/2024 - 08/2015
3	Drug Therapy (Chemotherapy) 05/2023 - 05/2014
3	Radiotherapy 02/2022 - 08/2015
2	Precision Medicine 06/2024 - 01/2023
2	Length of Stay 07/2018 - 01/2018
1	Complementary Therapies (Alternative Medicine) 05/2024
1	Aftercare (After-Treatment) 09/2021
1	Fitness Trackers 09/2021
1	Adjuvant Radiotherapy 08/2021
1	Activities of Daily Living (ADL) 01/2021
1	Ambulatory Care (Outpatient Care) 05/2020
1	Colonic Pouches (S Pouch) 03/2020
1	Pedicle Screws 03/2017
1	Chemoradiotherapy 08/2015